NASDAQ:ATHA
Athira Pharma, Inc. Stock News
$2.71
+0.500 (+22.62%)
At Close: May 16, 2024
Athira Pharma extends Alzheimer's clinical trial, adds new execs after CEO placed on leave
07:37pm, Monday, 16'th Aug 2021
Athira Pharma is advancing its clinical trials in the wake of allegations of image manipulation in papers authored by its CEO, the company reported today in its second quarter financial and business u
Athira Pharma Reports Second Quarter 2021 Financial Results and Business Update
04:01pm, Monday, 16'th Aug 2021
- Initiated open label extension for LIFT-AD and ACT-AD trials of ATH-1017 allowing for an additional six months of treatment
Wolf Popper LLP Reminds Athira Pharma, Inc. (ATHA) Investors of August 24, 2021 Lead Plaintiff Filing Deadline
07:00am, Monday, 16'th Aug 2021
New York, New York--(Newsfile Corp. - August 16, 2021) - Wolf Popper LLP reminds Athira Pharma, Inc. (NASDAQ: ATHA) investors that federal securities class action lawsuits have been filed in the U.S.
Radnor, Pennsylvania--(Newsfile Corp. - August 15, 2021) - The law firm of Kessler Topaz Meltzer & Check, LLP reminds Athira Pharma, Inc. (NASDAQ: ATHA) ("Athira") investors that securities fraud clas
Radnor, Pennsylvania--(Newsfile Corp. - August 14, 2021) - The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors that securities fraud class action lawsuits have been filed against Athi
NEW YORK, Aug. 13, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Athira Pharma, Inc. (NASDAQ: ATHA): (a) pursuant and/or traceabl
San Francisco, California--(Newsfile Corp. - August 13, 2021) - Hagens Berman urges Athira Pharma, Inc. (NASDAQ: ATHA) investors with significant losses to submit your losses now. A securities class
Lawsuits Filed Against ATHA, YMM and PLL - Jakubowitz Law Pursues Shareholders Claims
03:10pm, Thursday, 12'th Aug 2021
NEW YORK, NY / ACCESSWIRE / August 12, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies w
Los Angeles, California--(Newsfile Corp. - August 12, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Athira Pharma,
New York, New York--(Newsfile Corp. - August 11, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Athira Pharma, Inc. (NASDAQ: ATHA): (a) pursuan
San Francisco, California--(Newsfile Corp. - August 11, 2021) - Hagens Berman urges Athira Pharma, Inc. (NASDAQ: ATHA) investors with significant losses to submit your losses now. A securities class
Los Angeles, California--(Newsfile Corp. - August 11, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Athira Pharma,
SHAREHOLDER ALERT: ATHA RKT ATVI: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
05:40am, Wednesday, 11'th Aug 2021
NEW YORK, NY / ACCESSWIRE / August 11, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a
Los Angeles, California--(Newsfile Corp. - August 10, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Athira Pharma,
Radnor, Pennsylvania--(Newsfile Corp. - August 7, 2021) - The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors of Athira Pharma, Inc. (NASDAQ: ATHA) ("Athira") that securities fraud cl
